Baidu
map

普通外科指南

订阅

MedSci主页 / 所有栏目 / 普通外科指南

2020 EHS/AHS指南：脐疝和上腹疝的治疗

2020-01-09 欧洲疝学会 Br J Surg. 2020 Jan 9.

:脐疝上腹疝

2020年1月，欧洲疝学会(EHS)联合美国疝学会(AHS)共同发布了脐疝和上腹疝的治疗指南，脐疝和上腹疝的治疗修补术是一种常见的外科手术，其并发症发生率低。本文作为第一步欧美联合治疗指南，主要针对脐疝和上腹疝的治疗提出指导建议。

中文标题：

2020 EHS/AHS指南：脐疝和上腹疝的治疗

英文标题：

Guidelines for treatment of umbilical and epigastric hernias from the European Hernia Society and Americas Hernia Society.

发布机构：

欧洲疝学会

发布日期：

2020-01-09

简要介绍：

2020年1月，欧洲疝学会(EHS)联合美国疝学会(AHS)共同发布了脐疝和上腹疝的治疗指南，脐疝和上腹疝的治疗修补术是一种常见的外科手术，其并发症发生率低。本文作为第一步欧美联合治疗指南，主要针对脐疝和上腹疝的治疗提出指导建议。

 

拓展指南：与疝相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 EHS/AHS指南：脐疝和上腹疝的治疗)] GetToolGuiderByIdResponse(projectId=1, id=eb2a11c0018508b7, title=2020 EHS/AHS指南：脐疝和上腹疝的治疗, enTitle=Guidelines for treatment of umbilical and epigastric hernias from the European Hernia Society and Americas Hernia Society., guiderFrom=Br J Surg. 2020 Jan 9., authorId=null, author=, summary=2020年1月，欧洲疝学会(EHS)联合美国疝学会(AHS)共同发布了脐疝和上腹疝的治疗指南，脐疝和上腹疝的治疗修补术是一种常见的外科手术，其并发症发生率低。本文作为第一步欧美联合治疗指南，主要针对脐疝和上腹疝的治疗提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=1017, associationName=欧洲疝学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jan 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月，欧洲疝学会(EHS)联合美国疝学会(AHS)共同发布了脐疝和上腹疝的治疗指南，脐疝和上腹疝的治疗修补术是一种常见的外科手术，其并发症发生率低。本文作为第一步欧美联合治疗指南，主要针对脐疝和上腹疝的治疗提出指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>疝</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=beec31c001825eac" title="国际内镜疝学会腹壁疝和切口疝腹腔镜治疗指南更新解读（二）" target=_blank>国际内镜疝学会腹壁疝和切口疝腹腔镜治疗指南更新解读（二）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=9ce2f1c001e721cf" title="腹股沟疝日间手术规范化流程专家共识（2019 版）" target=_blank>腹股沟疝日间手术规范化流程专家共识（2019 版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a98d71c001e566eb" title="2019 IEHS指南：腹壁疝和腹壁切口疝的内镜治疗（更新版）-A" target=_blank>2019 IEHS指南：腹壁疝和腹壁切口疝的内镜治疗（更新版）-A</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=516aa1c001e1558f" title="疝外科缝合技术与缝合材料选择中国专家共识（2018版）" target=_blank>疝外科缝合技术与缝合材料选择中国专家共识（2018版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a4b701c0016160fb" title="腹壁切口疝诊断和治疗指南（2018 年版）" target=_blank>腹壁切口疝诊断和治疗指南（2018 年版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%96%9D" target=_blank>有关疝更多指南</a></ul>, tagList=[TagDto(tagId=70530, tagName=:), TagDto(tagId=50871, tagName=脐疝), TagDto(tagId=98887, tagName=上腹疝)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4900, appHits=187, showAppHits=0, pcHits=2052, showPcHits=3879, likes=35, shares=7, comments=4, approvalStatus=1, publishedTime=Fri Jan 17 23:47:48 CST 2020, publishedTimeString=2020-01-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 17 23:47:48 CST 2020, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 15:15:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 EHS/AHS指南：脐疝和上腹疝的治疗)])
2020 EHS/AHS指南：脐疝和上腹疝的治疗
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1015709, encodeId=9edd1015e092f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:29:47 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925171, encodeId=20ad9251e14a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:43:22 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892282, encodeId=a076892282f4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837a5305959, createdName=14878565m73(暂无昵称), createdTime=Thu Oct 15 19:42:06 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884788, encodeId=d4c6884e8876, content=写的非常好，很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4aca5193398, createdName=14720424m29暂无昵称, createdTime=Sat Sep 12 17:51:33 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2021-09-08 ms6000001820586697

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1015709, encodeId=9edd1015e092f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:29:47 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925171, encodeId=20ad9251e14a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:43:22 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892282, encodeId=a076892282f4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837a5305959, createdName=14878565m73(暂无昵称), createdTime=Thu Oct 15 19:42:06 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884788, encodeId=d4c6884e8876, content=写的非常好，很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4aca5193398, createdName=14720424m29暂无昵称, createdTime=Sat Sep 12 17:51:33 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2021-02-18 ms4000001482550161

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1015709, encodeId=9edd1015e092f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:29:47 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925171, encodeId=20ad9251e14a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:43:22 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892282, encodeId=a076892282f4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837a5305959, createdName=14878565m73(暂无昵称), createdTime=Thu Oct 15 19:42:06 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884788, encodeId=d4c6884e8876, content=写的非常好，很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4aca5193398, createdName=14720424m29暂无昵称, createdTime=Sat Sep 12 17:51:33 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-10-15 14878565m73(暂无昵称)

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1015709, encodeId=9edd1015e092f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58185598975, createdName=ms6000001820586697, createdTime=Wed Sep 08 15:29:47 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925171, encodeId=20ad9251e14a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:43:22 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892282, encodeId=a076892282f4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837a5305959, createdName=14878565m73(暂无昵称), createdTime=Thu Oct 15 19:42:06 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884788, encodeId=d4c6884e8876, content=写的非常好，很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4aca5193398, createdName=14720424m29暂无昵称, createdTime=Sat Sep 12 17:51:33 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-12 14720424m29暂无昵称

    写的非常好，很有帮助

    0

相关指南

2019 多学科共识文件：转移性激素敏感和转移性去势抵抗性前列腺癌患者的监测

国外肿瘤科相关专家小组（统称） · 2019-12-01

2019 SIA意见书：晚期酒精性肝病和重症急性酒精性肝炎的管理

意大利酒精协会 · 2019-11-19

2019 意大利共识建议：轻度认知功能障碍基于生物标志物的病因诊断

国外神经内科相关专家小组（统称） · 2019-11-06

2019 EHRA国际共识：心脏植入性电子设备感染的预防，诊断和治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2019-11-08

国际内镜疝学会腹壁疝和切口疝腹腔镜治疗指南更新解读（二）

暂未更新 · 2019-10-30

2019 ESPGHAN指南：乳糜泻的诊断

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2019-09-17

Baidu
map
Baidu
map
Baidu
map